HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: hrt.2007.134890v1 hrt.2007.134890v2 94/1/34    most recent Submit a response Read responses to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hippisley-Cox, J Articles by Brindle, P Search for Related Content PubMed PubMed Citation Articles by Hippisley-Cox, J Articles by Brindle, P Topic Collections Editor's choice Relevant Article

Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study

¹ Division of Primary Care, University Park, Nottingham, UK
² Centre for Health Sciences, Queen Mary’s School of Medicine and Dentistry, London, UK
³ Avon Primary Care Research Collaborative, Bristol Primary Care Trust, Bristol, UK

Correspondence to:
Professor J Hippisley-Cox, Division of Primary Care, 13th Floor, Tower Building, University Park, Nottingham NG2 7RD, UK; Julia.hippisley-cox{at}nottingham.ac.uk

Aim: To assess the performance of the QRISK score for predicting cardiovascular disease (CVD) in an independent UK sample from general practice and compare with the Framingham score.

Design: Prospective open cohort study

Setting: UK general practices contributing to the THIN and QRESEARCH databases.

Cohort: The THIN validation cohort consisted of 1.07 million patients, aged 35–74 years registered at 288 THIN practices between 1 January 1995 and 1 April 2006. The QRESEARCH validation cohort consisted of 0.61 million patients from 160 practices (one-third of the full database) with data until 1 January 2007. Patients receiving statins, those with diabetes or CVD at baseline were excluded.

End point: First diagnosis of CVD (myocardial infarction, coronary heart disease (CHD), stroke and transient ischaemic attack) recorded on the clinical computer system during the study period.

Exposures: Age, sex, smoking status, systolic blood pressure, total/high-density lipoprotein cholesterol ratio, body mass index, family history of premature CHD, deprivation and antihypertensive medication.

Results: Characteristics of both cohorts were similar, except that THIN patients were from slightly more affluent areas and had lower recording of family history of CHD. QRISK performed better than Framingham for every discrimination and calibration statistic in both cohorts. Framingham overpredicted risk by 23% in the THIN cohort, while QRISK underpredicted risk by 12%.

Conclusion: This analysis demonstrated that QRISK is better calibrated to the UK population than Framingham and has better discrimination. The results suggest that QRISK is likely to provide more appropriate risk estimates than Framingham to help identify patients at high risk of CVD in the UK.

This article has been cited by other articles:

				R. Jackson, S. Wells, and A. Rodgers Will screening individuals at high risk of cardiovascular events deliver large benefits? Yes BMJ, August 28, 2008; 337(aug28_2): a1371 - a1371. [Full Text]

				J. Hippisley-Cox, C. Coupland, Y. Vinogradova, J. Robson, R. Minhas, A. Sheikh, and P. Brindle Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 BMJ, June 28, 2008; 336(7659): 1475 - 1482. [Abstract] [Full Text] [PDF]

				R. Jackson Cardiovascular risk prediction: are we there yet? Heart, January 1, 2008; 94(1): 1 - 3. [Full Text] [PDF]

eLetters: